Magnesium (Heart).

The sodium-potassium pump that maintains a normal cardiac cell membrane potential runs on magnesium-ATP. Low magnesium status makes the kidney lose potassium, so the two minerals set each other's ceiling.

Magnesium-dependent enzymes carry out both hydroxylation steps that turn vitamin D into its active form. Higher vitamin D intake also increases magnesium turnover.

Pyruvate dehydrogenase and transketolase use thiamine pyrophosphate with magnesium in the active site, so cardiac carbohydrate oxidation needs both. Thiamine intake without magnesium status is incomplete.

The two divalent minerals compete for intestinal uptake at large single doses, so spacing them keeps both. In heart muscle calcium drives contraction and magnesium supports relaxation, which is a balance rather than a stack.

B6 helps magnesium move into cells and stay there, which matters most in tissue with high magnesium turnover.

Taurine is used as the amino acid counter-ion in magnesium taurate, so the two arrive together by design rather than by chance. Taurine itself participates in cellular calcium handling and osmotic balance, the same processes magnesium influences from the other side of the membrane. The pairing is formulation convention with a shared physiological theme, not a tested combination outcome.

Large single doses of zinc and magnesium share divalent cation absorption routes in the small intestine and can reduce each other's uptake when taken together at high amounts. At ordinary supplemental amounts the interaction is small and both are routinely present in the same multi-mineral products. Separating large doses across the day is the usual formulation answer.

Iron and magnesium both cross the enterocyte partly through divalent metal transport, and a large dose of one lowers fractional absorption of the other in the same meal. This is a kinetic competition, not a loss of either mineral from the body. Products that carry both usually space them or accept the reduced fractional uptake.

Vitamin K dependent proteins such as matrix Gla protein carry carboxylated glutamate residues that bind calcium and influence where mineral is deposited in soft tissue and bone. Magnesium supports the normal handling of calcium at the same tissues through its role in parathyroid hormone signalling. The two act on the same mineral distribution question from different angles, which is why they are formulated together.

Coenzyme Q10 shuttles electrons between complex I or II and complex III of the respiratory chain, and the ATP that emerges is biologically active as a magnesium complex. Magnesium is required by the ATP synthase reaction and by most downstream kinases that spend that ATP. Pairing them puts one nutrient at the point of production and one at the point of use.

Creatine kinase transfers a phosphate between phosphocreatine and ADP, and the substrate the enzyme actually binds is the magnesium ADP complex. Without adequate magnesium the reaction runs poorly no matter how much creatine is present. The relationship is settled enzymology rather than a tested supplement combination.

Dietary nitrate raises nitric oxide availability and relaxes vascular smooth muscle, while magnesium contributes to smooth muscle relaxation through its influence on calcium entry. Taken together the two push blood pressure in the same direction, which matters for anyone already tracking their numbers. The additive direction is mechanistically expected; the size of any combined shift has not been measured here.

Cellular potassium gradients depend on the sodium potassium ATPase, an enzyme whose substrate is magnesium bound ATP, and on ROMK channels that magnesium gates from the inside. When magnesium status is low, potassium is lost in the urine and is difficult to restore by potassium alone. Correcting magnesium is what allows potassium repletion to hold.

High sodium intake increases urinary magnesium loss because the two share handling in the loop of Henle and distal tubule. The relationship runs through renal reabsorption rather than through absorption in the gut. It is a reason magnesium requirements track dietary pattern, not a reason to avoid either.

Fermentable fibres are broken down by colonic bacteria into short chain fatty acids that lower luminal pH and increase the soluble fraction of divalent minerals, including magnesium, available for passive colonic uptake. Most of the direct measurement is in animals with a smaller human literature. The effect is on fractional absorption, a marker, not on any clinical endpoint.

Phosphate binds magnesium in the gut lumen to form poorly soluble magnesium phosphate, which lowers the fraction absorbed when a large phosphate load and a magnesium dose arrive in the same meal. Phosphate-heavy foods and phosphate binders both do this. Spacing the two is the practical response.

Boron has been reported to reduce urinary loss of magnesium and calcium in small human balance studies. The measurements are of urinary excretion, a marker of handling, not of bone or cardiovascular outcomes. Read it as mechanistic rather than clinical.

Riboflavin becomes useful only after conversion to FMN and FAD, and both steps are ATP dependent kinase and adenylyltransferase reactions that require magnesium. Low magnesium status slows the activation of dietary riboflavin. This is settled cofactor biochemistry.

Glycine serves as the chelating amino acid in magnesium bisglycinate, producing a neutral complex that is absorbed partly through amino acid routes rather than only as a free divalent cation. Glycine also has its own role as an inhibitory neurotransmitter and a collagen building block. The pairing is a delivery decision, and each component has separate uses.